# AstraZeneca, Ionis report major trial failure with heart disease drug

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-09 15:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Executive Summary
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.

## Intelligence Brief
"AstraZeneca, Ionis report major trial failure with heart disease drug" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by Newsylist so far.


Outlets currently covering the story include Yahoo Finance, Reuters, WSJ and CNBC. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### Why is "AstraZeneca, Ionis report major trial failure with heart disease drug" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

### How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

### Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

## Key People, Organizations & Locations
Years, AstraZeneca, AstraZeneca Ionis, IONS Stock Heads Toward Biggest Single-Day Slump In Over, AstraZeneca's Wainua, AstraZeneca Ionis Stocks Stumble After Heart Drug Fails Key Trial

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| MarketWatch | Major drugmaker loses $27 billion in market value after failed trial | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxNOTE1ZUVpM0JacEM0LVBreVNhOGdNU3JnVlZEd0d2Z2Z5ZUI3S25fTmtsQzJ5UmhQSGFUbkgwTFVTTHJmMlNkbTdpYzVSa0p0Z0FqcnlkUWoxSnpkVEdKNzZzMFFudzB6bUt1RUlHZWVwMkd3cWg3Yy12ZDJTZUZEMVJGOVVYRmhBNjlyLWE4QnFrcFdMaUFUc01lR3o3cXhVelZuQThLSWxUNENNaEtZ?oc=5) |
| Fierce Pharma | AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxNYnIxNnFVb29FWjVvTHBlT2Njd0Jjb29ZUEtxVXlfck8yOGJTcG4zcFVqaDlKX3BMMFlDcG9uUVBvUWctWnFoT0Y3OGJCYlFQQkxDRVJ3dlJtWFc0cGMyTVRfLWVJckc4VjA1OTRvcnV2UkFlNTZtX0Z0OW1hdUxmcFhtMjdENWdXT2gzWjVLbWJScHZ6SWNGMWY3bHoyQQ?oc=5) |
| Yahoo Finance | IONS Stock Heads Toward Biggest Single-Day Slump In Over 5 Years | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxQeG9CdklqbEhhbTlBVDIwdDIzM05PMTB3VkFCQkxGc1l6c2Q1Q18tdnh1MFVmQzgtd3hhUnJpN1FLaEp2YmZTQ2IxRElKLWpnSHBWZ0Y5aG1zRld2ZkFhNDZ0ei1WZnotNmxxdEtvVVk1YUQ5UTBaUy1renhFT3Q1VUhEYkVZMlV2NlZpTG9sc0QzY1g4bGlRbEtOSmk?oc=5) |
| Reuters | AstraZeneca's Wainua fails key heart disease trial, shares tumble | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxNT1hfTDNWX2IwRHVtOFA5eGxKRWNuWjJOT3Vyd04yUXViOWRGUWxUMmxOVl9fZmV3Z0c4X3BpV2FrVFhRUHg2T1JRMDVaTndpZEZ6WnJ5SXo3c1l5N3BsTXphblBhOENEbG5ueUpxNFl3LUlWMGZXYkduaHNVZ0c3N0JqZTh4dWVpWTNDaUpHdFV6WWpVUUcxTHJfR2x6dHVvTl9KdW9GbVctTFFxbXEwMTdLQVBpQ3Y5dzE3RXdfczNYaDBCLUtMbGJRM0NvU2V3bE9LMlcyNGtpazF5Y21r?oc=5) |
| WSJ | AstraZeneca, Ionis Stocks Stumble After Heart Drug Fails Key Trial | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMiggJBVV95cUxNTUR5YVZQS1hfQkFiVUZVS0oxMXBkVUxraTFCbEZoQ3hYVUs4QVFydDBfXzByOElIX281Vl8tdkM1cHJmQXI5QzhWZW5ZckVweG1pSDdEU1J5LXdHYkJsTDJ5RElyd2FGQl9sMks2bmJRUjdTQUtDMm5FbHp0aFZGZlBzRWY1MUtKMWVObG5UbjhJZDRIakN3dG5qQmE0cHpYam95WTdCdEluc2dOcFZRQ2Q5ZXRwRzhNUTlMcmFLMV9XMkRzUW1xSmdsZWE0Z2UzNnE3Q1hSWXRUOEhUN3VVd0lvNDh1aWZSM24zWU8xVUZuS2g3VkRUcW4zNHdGaTllN1E?oc=5) |
| CNBC | AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPMDQyN2hzSzZrYVFOY3F1RUtzSENYRlUyZk5zaHBZVERYQVY1V0UwN2thZXNqQW5vdXctUFR4emVhVjdSaGt0WjdIMFMwZ1A3LXYzczFpWkJ5TDIxd0E4RGNfYzR1SndVU3lXcm9yUFhZT0c5MExOM0xkRjl5VGJjSS1NN2jSAYoBQVVfeXFMT1J2UFFLZ2huendrTThlUnVkTU4zUHFMd3dfMVJyYmxSSVNaanBmbFNELTVGMjZuVGlnWk1sQThWMmlaVUNZTFBNblRGWTBSb1NGeXBacW9hamlGNjFKZnB5V2VmMlVfYjRsQjlZdkZJM2RxUGpHX0MyMXJmUTM0ZGtzWVlEZ2RtcVhn?oc=5) |
| STAT | AstraZeneca, Ionis report major trial failure with heart disease drug | 2026-07-09 13:00 | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxPQ1VFdDBSUkZhRk9nQUc2bWRMdGlLdXFnUFpaNFcwUWJ2dUhwT2NBMnM2MG5NblJ3M0c2emJvajh2VWQ2MTkwXzlJWFVxSmZtaW41VEhvU3hlMWQ1YzRoZV9ZcU9MOC1aWl9yMWFIODkzeXY2VEJDaW5yWGJIMkM1Y190TVNrV2M?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-09/astrazeneca-ionis-report-major-trial-failure-with-heart-disease-drug*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*